Antipodean Advisors LLC
- SEC CIK
- 0001512566
- Latest filing
- Nov 14, 2023
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 8
- 0 vs. Q4 2022
- Portfolio value
- $16.2M
- −$13.8M (−46.0%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SESea Ltd | SPONSORD ADS | 70,000 | $6.06M | 37.5% | −280,000−80.0% | Reduced | History |
| Investment Managers Ser Tr I46144X867 | AXS TSLA BEAR DL | 75,000 | $3.19M | 19.7% | +75,000 | New | – |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $2.90M | 17.9% | 00.0% | Unchanged | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 75,000 | $2.43M | 15.0% | +65,000+650.0% | Added | – |
| CMAXCareMax, Inc. | COM CL A | 425,000 | $1.13M | 7.0% | 00.0% | Unchanged | History |
| COINCoinbase Global, Inc. | COM CL A | 3,500 | $236.5K | 1.5% | +3,500 | New | History |
| CDLXCardlytics, Inc. | COM | 35,000 | $118.8K | 0.7% | −40,000−53.3% | Reduced | History |
| CVNACarvana Co. | CL A | 10,000 | $97.9K | 0.6% | −15,000−60.0% | Reduced | History |
Sold out since Q4 2022 (2)
Positions held at the end of Q4 2022 that are gone from this filing.